The Effect of Rectus Muscle Approximation at Cesarean Delivery on Pain Perceived After Operation

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT03306953
Collaborator
(none)
280
1
2
3.3
84.4

Study Details

Study Description

Brief Summary

This is a prospective randomized controlled study to determine the clinical outcome of rectus muscle re-approximation at Cesarean delivery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Rectus muscle approximation
N/A

Detailed Description

This is a prospective randomized controlled study to determine the clinical outcome of rectus muscle re-approximation at Cesarean delivery. Postoperative pain will be assessed in 2 groups. Rectus muscle approximation will be done to the first group. The second group will be the control group.

Study Design

Study Type:
Interventional
Actual Enrollment :
280 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Effect of Rectus Muscle Approximation at Cesarean Delivery on Postoperative Pain
Actual Study Start Date :
Oct 11, 2017
Actual Primary Completion Date :
Jan 15, 2018
Actual Study Completion Date :
Jan 20, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Rectus muscle approximation

Three sutures will be done for the the purpose of rectus muscle approximation in cesarean section.

Procedure: Rectus muscle approximation
The surgeon will take sutures to approximate rectus muscles at the end of cesarean delivery.

No Intervention: Control

No approximation for the rectus muscle will be done for the control group in cesarean section.

Outcome Measures

Primary Outcome Measures

  1. Early pain score [24 hours after cesarean section]

    Early pain score will be assessed by an investigator for patients

Secondary Outcome Measures

  1. Late pain score [48 hours after cesarean section]

    Late pain score will be assessed by an investigator for patients

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women who will undergo first elective cesarean section

  • Singleton pregnancy

Exclusion Criteria:
  • Previous abdominal or pelvic surgery

  • Medical or psychiatric disease

  • Previous pelvic inflammatory disease

  • Obesity

  • Allergy to analgesics

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Obstetrics and Gynecology, Kasr Al-Ainy hospital Cairo Greater Cairo Egypt 11956

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: Eman F Omran, M.D., Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eman Omran, principal investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT03306953
Other Study ID Numbers:
  • 5678
First Posted:
Oct 11, 2017
Last Update Posted:
Feb 5, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 5, 2018